A1 Refereed original research article in a scientific journal

Stroma‐and Tumor‐Associated Predictive Features in Salivary Gland Adenoid Cystic Carcinoma of the Head and Neck




AuthorsRytkönen, Aleksi; Laine, Hanna K.; Mäkitie, Antti; Haglund, Caj; Hagström, Jaana; Almangush, Alhadi; Leivo, Ilmo

PublisherWiley

Publication year2025

JournalJournal of Oral Pathology and Medicine

Journal name in sourceJournal of Oral Pathology & Medicine

Journal acronymJ Oral Pathol Med

Volume54

Issue1

First page 22

Last page30

ISSN0904-2512

eISSN1600-0714

DOIhttps://doi.org/10.1111/jop.13589

Web address https://doi.org/10.1111/jop.13589

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/470861768


Abstract

Background: There is lack of knowledge on the utility of prognostic histopathologic characteristics in adenoid cysticcarcinoma (ACC) of the head and neck. We evaluated the prognostic value of tumor and stroma-related histopathologicfeatures in ACC.

Materials and Methods: A total of 65 cases of ACC from minor and major salivary glands were included in this study. Weevaluated tumor budding, tumor-infiltrating lymphocytes (TILs), and tumor-stroma ratio (TSR) in hematoxylin and eosin (HE)stained sections.

Results: Stroma-rich ACCs recurred more frequently (p = 0.029) during follow-up and associated with distant metastasis(p = 0.038). In multivariable analysis, stroma-rich tumors associated with poorer disease-specific survival with a hazardratio of 3.76 (95% CI 1.10–12.83, p = 0.034). ACCs commonly showed a low infiltration of TILs as 89% of the tumors wascharacterized by an immune desert pattern. Low infiltration of TILs associated significantly with increased tumor budding(p = 0.039).

Conclusion: Adverse features of TSR and tumor budding are widely expressed in ACC, and stroma-rich tumors are associatedwith poor prognosis. Low number of TILs in ACC tissue indicates a weak immune response by the host and illustrates the natureof ACC as a relentless malignancy.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This study was funded by Läkaresällskapet, the Finnish Cancer Society, Turku University Hospital Fund, Maritza and Reino Salonen Foundation.


Last updated on 2025-27-03 at 12:07